Related Experiment Videos
Calcium antagonists stimulate sperm motility in ejaculated human semen
British Journal of Clinical Pharmacology
|January 1, 1985
Summary
Calcium antagonists like diltiazem significantly improved human sperm motility in vitro. This suggests a potential therapeutic role for these drugs in treating male infertility, pending further research.
Area of Science:
- Reproductive biology
- Pharmacology
- Cell physiology
Background:
- Sperm motility is crucial for natural fertilization.
- The role of intracellular calcium in sperm function is complex and not fully understood.
- Previous hypotheses suggest high intracellular calcium may impair sperm motility.
Purpose of the Study:
- To investigate the in vitro effects of calcium antagonists on human sperm motility.
- To explore the relationship between calcium concentration and sperm motility.
- To determine if calcium antagonists could be a potential treatment for subfertility.
Main Methods:
- Human sperm samples were incubated in vitro.
- Sperm motility was assessed after exposure to various calcium antagonists (diltiazem, flunarizine, verapamil).
- Concentration-response curves were analyzed, and interactions with calcium chelators (EGTA) and ionophores (A23187) were examined.
Main Results:
- Diltiazem, flunarizine, and verapamil all demonstrated a stimulatory effect on human sperm motility.
- Diltiazem produced the most significant increase in motility amplitude.
- EGTA enhanced diltiazem's effect, while A23187 antagonized it, supporting the detrimental role of high calcium.
Conclusions:
- Calcium antagonists can enhance human sperm motility in vitro.
- The findings support the hypothesis that elevated intracellular calcium negatively impacts sperm motility.
- Further clinical investigation is warranted to evaluate the therapeutic potential of calcium antagonists for subfertile patients.